IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login
Users Online :3856
Small font sizeDefault font sizeIncrease font size
About Editorial Board Ahead of print Current Issue Archive Search Instructions Announcement Etcetera Contact Advertise
Navigate Here
  »   My Preferences 
  »   Manuscript submission
  »   Back To Article

» Article Access Statistics 

Year : 2017 | Volume:  49 | Issue Number:  6 | Page:  451-457

RESEARCH ARTICLE

Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study
Shivaprakash G, Udupa Karthik S, Sarayu V, Thomas Joseph, Gupta Vishal, Pallavi L C, Pemminati Sudhakar

Number of times this article was viewed 4894
Number of times this article has been printed  from the site 131
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow